Prime Stock alert: Moving this pharma stock to a HOLD
Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.
No more tall claims or frivolous guarantees.
Only quality, long-term growth.
Deep-dive into lesser-known stocks
Get buy calls, at the right time & right price
Receive alerts on booking profits or selling
Get a heads up on stocks in our watchlist
Use smart filters for DIY investing decisions
This stock’s potential hinges on FMCG growth, and gets the same ‘defensive’ tag that FMCG does. But, unlike FMCGs, it doesn’t trade at multi-year highs.
This company ticks every box – a great customer market, access to low-cost funding, comfortable capital cushion, well-provisioned for potential NPAs, and reasonable valuations
This stock wins on superior margins, pricing power, and vast retail market access. All this with great valuations and steady dividends providing a moat.
Looking to buy investment-friendly stocks that come with long-term payoffs? Prime Stocks provides an expertly-curated list of stocks from which you can choose.
We also provide real-time updates on our coverage and when to accumulate, book profits or sell.
Been in the game long enough to know what you are looking for? Prefer to do your own research? Prime Stocks puts you in the driver’s seat.
Our stock screener tool lets you do your own stock analysis with the right evaluation metrics and data.
Want to do your own analysis but don’t quite know where to start? Or looking for unique filters like steady dividend payouts or rising profits or higher FII holding?
Our pre-built screeners give you a great base and it’s easy for you to add on other different filters for a great shortlist.
Eager to unearth lesser-known stocks that can turn out to be hidden gems? We dive deep into stock performers and numbers to review lesser-known or up-and-coming stocks.
Our in-depth analysis and data on stocks will keep you two steps ahead and keep you informed on all that’s going on in the world of stocks.
with stock recommendations, reviews & filtering tools
model with advanced metrics to measure stock strength & growth
on shortlisted stocks to pick the best of long-term potential
on recommended stocks – hold, book profits or sell at the right time
with filters and metrics that aren’t easily available like NPAs or cash flow growth
on standalone/ consolidated financials, prices, past valuations & more
Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.
A report from Kotak Institutional Equities sparked a bout of selling in mid and small caps. Should you be concerned? Here is what we think.
As stocks across market caps have run up, we are taking a look at Prime Stocks with a special focus on valuations and are moving these two stocks to a ‘HOLD’.
Prime Stocks is purely for long-term investors who want to supplement their portfolio of mutual funds, deposits, or ETFs with quality stocks. It is not meant for active stock-only investors who wish to have frequent ‘buy’ or ‘reduce’ calls.
We do not provide any target price for our stocks as we think they are meant for long-term holding. However, in case of any valuations that may be out of sync with growth prospects or other governance or regulatory risks, we will issue a sell call or even ‘book profits’ calls.
We also do not use any technical analysis to pick Prime stocks.
This is not an advisory service. Hence, we will not provide any advice on your stock holdings or
review them.
We will respond only to queries relating to the recommendations in our list. We will not respond to individual stock queries. We also retain the discretion to review stocks that we find worthy and do not cover stocks on your request.
Our filters and screeners are not our recommendations. They are tools meant for your analysis. We do not provide any research on screeners that you run.
We do not guarantee any returns on stocks that we recommend and are not liable for any losses you may incur based on the recommendations.
We do not have any platform to provide any execution service. We also do not manage your money in any form.
Legal Disclaimer : PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). The content and reports generated by the entity does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities. All content and information are provided on an ‘as is’ basis by PrimeInvestor Financial Research Pvt Ltd. Information herein is believed to be reliable but PrimeInvestor Financial Research Pvt Ltd does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by PrimeInvestor Financial Research Pvt Ltd are on a best-effort basis. PrimeInvestor Financial Research Pvt Ltd does not assure or guarantee the user any minimum or fixed returns. PrimeInvestor Financial Research Pvt Ltd or any of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates will not liable for any losses, cost of damage incurred consequent upon relying on investment information, research opinions or advice or any other material/information whatsoever on the web site, reports, mails or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Use of the above-said information is at the user’s own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. All intellectual property rights emerging from this website, blog, and investment solutions are and shall remain with PrimeInvestor Financial Research Pvt Ltd. All material made available is meant for the user’s personal use and such user shall not resell, copy, or redistribute the newsletter or any part of it, or use it for any commercial purpose. PrimeInvestor Financial Research Pvt Ltd, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its research or investment information. The performance data quoted represents past performance and does not guarantee future results. Investing in financial products involves risk. Investments are subject to market risk. Please read all related documents carefully. As a condition to accessing the content and website of PrimeInvestor Financial Research Pvt Ltd, you agree to our Terms and Conditions of Use, available here. This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
• Aditya Birla Mutual Fund • Axis Mutual Fund • Baroda Mutual Fund • BNP Paribas Mutual Fund • BOI AXA Mutual Funds • Canara Robeco Mutual Fund • DSP Mutual Fund • Edelweiss Mutual Fund
• Essel Mutual Fund • Franklin Templeton Mutual Fund • HDFC Mutual Fund • HSBC Mutual Fund • ICICI Mutual Fund • IDBI Mutual Fund • IDFC Mutual Fund • IIFL Mutual Fund • Indiabulls Mutual Fund • Invesco Mutual Fund • ITI Mutual Fund • Kotak Mahindra Mutual Fund • L&T Mutual Fund • LIC Mutual Fund • Mahindra Mutual Fund • Mirae Asset Mutual Fund • Motilal Oswal Mutual Fund • Nippon India Mutual Fund • PGIM Mutual Fund • PPFAS Mutual Fund • Quant Mutual Fund • Quantum Mutual Fund • Sahara Mutual Fund • SBI Mutual Fund • Shriram Mutual Fund • Sundaram Mutual Fund • Tata Mutual Funds • Taurus Mutual Funds • Union Mutual Funds • UTI Mutual Funds • Yes Mutual Funds
Equity: Large Cap Funds | Mip Cap Funds | Large And Mid Cap Funds | Small Cap Mutual Funds | Contra Mutual Funds | Dividend Yield | Focused Mutual Funds | Find Top Index Funds | Best Sector Funds | Thematic Mutual Fund | Best Value Mutual Funds | Equity Linked Savings Scheme | Tax Saving Funds
Debt: Banking And PSU Funds | Corporate Bond Funds | Credit Risk Funds Mutual Funds | Dynamic Bond Funds | Floating Rate Funds | Gilt Mutual Funds India | Find Top Liquid Funds In India | Long term debt funds | Low Duration Funds Debt Funds | Medium Duration Debt Funds | Medium To Long Duration Funds | Money Market Debt Funds | Overnight Debt Funds | Short Duration Debt Funds | Ultra Short Term Debt Fund
Hybrid: Aggressive Hybrid Funds | Arbitrage Mutual Funds | Balanced Advantage Mutual Funds | Conservative Hybrid Funds | Dynamic Asset Allocation | Equity Saving Funds | Multi Asset Funds | Multi Asset Allocation
Mutual fund rolling returns by category: Balanced Advantage | Conservative Hybrid Fund | Corporate Bond | Dividend Yield | Dynamic Bond | Equity Linked Savings Scheme | Floating Rate | Index Funds | Large and Midcap fund | Large Cap Fund | Liquid funds | Low Duration | Mid Cap Fund | Multi Cap Fund | Short Duration | Small cap Fund | Solution Oriented – Childrens Fund | Ultra Short Duration
Stocks by market-cap:
Large Cap Stocks |Mid Cap Stocks |Small Cap Stocks
Stocks by sector:
Auto |Auto & auto ancillaries |Banks |Capital goods |Cement |Chemicals |Construction & infrastructure |Consumer discretionary |Consumer durables |
E-commerce |Entertainment |Fertilizers |Finance |FMCG |Hotels & restaurants |IT |Jewellery |Logistics |Media |Metals & mining |Oil & gas |Packaging |Paper |Pharma & healthcare |Plastic products |Power |Realty |REIT |Retail |Sugar |Telecom |Textiles |Trading
Popular stocks:
Reliance Industries Ltd |Tata Consultancy Services Ltd |HDFC Bank Ltd |Hindustan Unilever Ltd |Infosys Ltd |Housing Development Finance Corporation Ltd |Kotak Mahindra Bank Ltd |ICICI Bank Ltd |Bajaj Finance Ltd |Bharti Airtel Ltd |ITC Ltd |Asian Paints Ltd |HCL Technologies Ltd |State Bank of India |Maruti Suzuki India Ltd